![]() |
Name |
7-Nor-Ergosterolide
|
Molecular Formula | C27H42O3 | |
IUPAC Name* |
(1R,3aR,5aS,7S,9aS,11aR)-7-hydroxy-9a,11a-dimethyl-1-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,3a,5a,6,7,8,9,10,11-decahydro-1H-indeno[4,5-c]isochromen-5-one
|
|
SMILES |
C[C@H](CCC(=C)C(C)C)[C@H]1CC[C@@H]2[C@@]1(CCC3=C2OC(=O)[C@@H]4[C@@]3(CC[C@@H](C4)O)C)C
|
|
InChI |
InChI=1S/C27H42O3/c1-16(2)17(3)7-8-18(4)20-9-10-21-24-22(12-14-26(20,21)5)27(6)13-11-19(28)15-23(27)25(29)30-24/h16,18-21,23,28H,3,7-15H2,1-2,4-6H3/t18-,19+,20-,21+,23-,26-,27-/m1/s1
|
|
InChIKey |
UPMCJHRCQLXGPP-GOZBUJHGSA-N
|
|
Synonyms |
7-Nor-Ergosterolide; CHEBI:70332; 7-Norergosterolide; CHEMBL1631979; DTXSID201099280; Q27138673; (1R,3aR,5aS,7S,9aS,11aR)-1-[(1R)-1,5-dimethyl-4-methylene-hexyl]-7-hydroxy-9a,11a-dimethyl-2,3,3a,5a,6,7,8,9,10,11-decahydro-1H-indeno[4,5-c]isochromen-5-one; (1R,3aR,5aS,7S,9aS,11aR)-1-[(1R)-1,5-Dimethyl-4-methylenehexyl]-2,3,3a,5a,6,7,8,9,9a,10,11,11a-dodecahydro-7-hydroxy-9a,11a-dimethylbenz[d]indeno[4,5-b]pyran-5(1H)-one; (1R,3aR,5aS,7S,9aS,11aR)-7-hydroxy-9a,11a-dimethyl-1-[(2R)-6-methyl-5-methylideneheptan-2-yl]-2,3,3a,5a,6,7,8,9,9a,10,11,11a-dodecahydrobenzo[c]cyclopenta[h]chromen-5(1H)-one; 1175710-03-8
|
|
CAS | 1175710-03-8 | |
PubChem CID | 50899854 | |
ChEMBL ID | CHEMBL1631979 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 414.6 | ALogp: | 6.7 |
HBD: | 1 | HBA: | 3 |
Rotatable Bonds: | 5 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 46.5 | Aromatic Rings: | 4 |
Heavy Atoms: | 30 | QED Weighted: | 0.419 |
Caco-2 Permeability: | -4.862 | MDCK Permeability: | 0.00003250 |
Pgp-inhibitor: | 0.982 | Pgp-substrate: | 0.006 |
Human Intestinal Absorption (HIA): | 0.002 | 20% Bioavailability (F20%): | 0.085 |
30% Bioavailability (F30%): | 0.168 |
Blood-Brain-Barrier Penetration (BBB): | 0.083 | Plasma Protein Binding (PPB): | 91.68% |
Volume Distribution (VD): | 1.061 | Fu: | 2.86% |
CYP1A2-inhibitor: | 0.179 | CYP1A2-substrate: | 0.275 |
CYP2C19-inhibitor: | 0.098 | CYP2C19-substrate: | 0.859 |
CYP2C9-inhibitor: | 0.271 | CYP2C9-substrate: | 0.082 |
CYP2D6-inhibitor: | 0.006 | CYP2D6-substrate: | 0.079 |
CYP3A4-inhibitor: | 0.858 | CYP3A4-substrate: | 0.636 |
Clearance (CL): | 7.381 | Half-life (T1/2): | 0.059 |
hERG Blockers: | 0.009 | Human Hepatotoxicity (H-HT): | 0.034 |
Drug-inuced Liver Injury (DILI): | 0.267 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.111 | Maximum Recommended Daily Dose: | 0.766 |
Skin Sensitization: | 0.753 | Carcinogencity: | 0.054 |
Eye Corrosion: | 0.137 | Eye Irritation: | 0.348 |
Respiratory Toxicity: | 0.963 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001603 | ![]() |
0.588 | D0K5WS | ![]() |
0.391 | ||
ENC005968 | ![]() |
0.588 | D08SVH | ![]() |
0.390 | ||
ENC005630 | ![]() |
0.537 | D0Y7LD | ![]() |
0.387 | ||
ENC002075 | ![]() |
0.474 | D03ZTE | ![]() |
0.383 | ||
ENC003557 | ![]() |
0.458 | D0G3SH | ![]() |
0.383 | ||
ENC006033 | ![]() |
0.414 | D0M4WA | ![]() |
0.378 | ||
ENC000125 | ![]() |
0.404 | D0T2PL | ![]() |
0.355 | ||
ENC000961 | ![]() |
0.397 | D02ZGI | ![]() |
0.355 | ||
ENC002206 | ![]() |
0.392 | D0OR2L | ![]() |
0.353 | ||
ENC005270 | ![]() |
0.390 | D02VPX | ![]() |
0.350 |